We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Pashley, the UK's most enduring bicycle manufacturer established in 1926, has been crafting hand-made bicycles for 97 years. Renowned for our classic designs, we also specialize in innovative products catering to a greener transport market. Our product offerings encompass three primary categories: Cargo Cycles which is Ideal for last-mile delivery, vending, and promotional purposes; Bike Share: Providing hire bikes and docks tailored for urban settings & Classic Cycles: Exquisite, traditionally hand-built bicycles for town and country rides.
days to go: Expired investment: £657,702
Gusto Organic makes premium award-winning soft drinks from 100% organic, plant-based, and Fairtrade ingredients. The company's range of 8 sugar-free energy drinks provides an exquisitely-flavored and ethical alternative to traditional soft drinks from popular brands. Gusto Organic was the official sponsor of soft drinks for the 2018 and 2019 Tour of Britain Pro Cycle race. It has made a double turnover in the course of two years. Last year, the company formed premium brand partnerships with The Waldorf Hilton, Eat17, Sourced Market, head offices of SKY TV, and Chiquito restaurants. Gusto Organic is planning to build its in-house sales team to deliver growth, increase its range, and develop a new range of organic tonics.
days to go: Expired investment: £460,400
A money transfer service allowing customers to send money worldwide at a lower cost compared to traditional methods. TransferGo has been gaining 1,000 customers a day since May 2018 and currently has over 700,000 users. They have processed almost £781m on their platform through 1.3m transactions and operate on a gross profit margin of 6.7%. TransferGo has 5 offices located in London, Berlin, Istanbul, Warsaw and Vilnius, with more than 100 employees globally. The company recently launched their new product, dubbed 'NOW', that enables users to send and receive monies in less than 30 minutes across borders. Revenue is generated via fixed transfer fees and currency conversion fees ranging from 0.0% to 2.2% per transaction. These fees are dependent on the currency's origin and the amount being transferred. A free option is available to customers whose transaction may take a couple of days to transfer. Funds are being raised to expand the business into emerging markets and introduce new products and services. This also means that TransferGo is aiming to provide local-language support and build new partnerships to attract more customers to their platform.
days to go: Expired investment: £11,297,362
Established in 2011, Crowdcube has become the market leader in the equity crowdfunding sector. The company has a 40% share of the UK market with over 620,000 investors registered on the platform that have invested more than £561m in pitches. This has resulted in nearly 800 successful campaigns and Crowdcube's revenue increasing by 33% from H1 2017 to H1 2018. Funds are being raised to scale the business by expanding further in the UK, as well as overseas.
days to go: Expired investment: £7,918,180
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph